Jonathan David Schwartz, See Remarks at ROCKET PHARMACEUTICALS, INC. (RCKT), sold 1,582 shares at $6.53 ($10K) on 2025-05-16, disclosed to the SEC on 2025-05-20.
Open-market sale of $10k RCKT by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| RCKT | SELL | 2025-08-18 | $34K | — | Filing → |
| RCKT | SELL | 2025-05-22 | $5K | — | Filing → |
| RCKT | SELL | 2025-02-27 | $357K | — | Filing → |